Why the study?
Cardiovascular disease determinants have been rising in Saudi Arabia, and Saudi Vision 2030 aims to reduce the clinical and economic burden of CVD.
This review highlights the rising burden of cardiovascular disease and its risk factors in Saudi Arabia and proposes public health measures, national registries, and digital solutions to improve surveillance and outcomes.
Urges enhanced CVD monitoring in Saudi Arabia; leaves open whether proposed registries and digital solutions improve outcomes.
Cardiovascular diseases (CVDs) remain a major health concern globally. While some risk factors for CVDs are non-modifiable, other determinants like obesity, hypertension, type-2 diabetes and dyslipidemia can be mitigated by a wide plethora of measures to control CVD morbidity and mortality. Those determinants have been on the rise in Saudi Arabia, exacerbated by sedentary lifestyle. The Saudi Vision 2030 aims to reduce CVD clinical and economic burden and to scale up vitality and longevity; in a new era of comprehensive healthcare. From a health economics standpoint, CVDs entail a burden on healthcare systems directly through expenditure and indirectly through years living with the disease, low productivity, premature morbidity and mortality. This manuscript reviews current CV health and unmet needs in Saudi Arabia, discusses G20 countries' initiatives on primary prevention: public health measures, awareness programs; and proposes national registries and digital solutions to facilitate population-specific research, improve CV surveillance and alleviate CVD burden in Saudi Arabia.
No takes yet. Share an insight, caveat, or question.
Tash et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: